Intravesical oxybutynin in the pediatric neurogenic bladder

被引：0
|
作者：
John Lazarus
机构：
[1] Red Cross Children's Hospital,Division of Urology
[2] University of Cape Town,undefined
来源：
Nature Reviews Urology | 2009年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Topical treatment of neuropathic bladder has been suggested as a viable alternative to oral anticholinergic therapy in children, offering greater efficacy and reduced side effects. Lazarus reviews the current status of intravesical oxybutynin use, warning that although it has proven effective in some studies, there remains a low level of evidence.
引用
收藏
页码：671 / 674
页数：3
相关论文
共 50 条
  • [31] INTRAVESICAL INSTILLATION OF OXYBUTYNIN HYDROCHLORIDE THERAPY FOR PATIENTS WITH A NEUROPATHIC BLADDER
    MIZUNAGA, M
    MIYATA, M
    KANEKO, S
    YACHIKU, S
    CHIBA, K
    PARAPLEGIA, 1994, 32 (01): : 25 - 29
  • [32] Intravesical oxybutynin: A local anesthetic effect on bladder C afferents
    De Wachter, S
    Wyndaele, JJ
    JOURNAL OF UROLOGY, 2003, 169 (05): : 1892 - 1895
  • [33] INTRAVESICAL ELECTROTHERAPY IN THE MANAGEMENT OF NEUROGENIC BLADDER DISEASE
    KAPLAN, WE
    RICHARDS, I
    JOURNAL OF UROLOGY, 1987, 137 (04): : A248 - A248
  • [34] Intravesical therapy for the treatment of neurogenic bladder in children
    Holland, AJA
    King, PA
    Chauvel, PJ
    ONeill, MK
    McKnight, DL
    Barker, AP
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1997, 67 (10): : 731 - 733
  • [35] Intravesical oxybutynin treatment for neurogenic detrusor overactivity. Efficacy and safety data from clinical practice with the first intravesical oxybutynin treatment authorized in Germany
    Schindler, O.
    Ho, H.
    Leidl, Q.
    Angermund, A.
    Elishar, R.
    Frech-Dorfler, M.
    Hirsch, A.
    Kalke, Y. -B.
    Kirschner-herrmanns, R.
    Tornic, J.
    Queissert, F.
    Rahnama'i, S.
    Rehme, C.
    Reitz, A.
    Schmitz, F.
    Schultz-lampel, D.
    Gedamke, M.
    UROLOGIE, 2024, 63 (07): : 693 - 701
  • [36] THE CHANGE OF URODYNAMIC PARAMETERS CLASSIFIED BY NEUROGENIC BLADDER TYPE AFTER TREATMENT OF OXYBUTYNIN CHLORIDE IN CHILDREN WITH NEUROGENIC BLADDER
    Baek, Minki
    Kang, Jung Yoon
    Kim, Dae Kyung
    Kim, Kwang Myung
    JOURNAL OF UROLOGY, 2011, 185 (04): : E329 - E330
  • [37] Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population
    Palmer, LS
    Zebold, K
    Firlit, CF
    Kaplan, WE
    JOURNAL OF UROLOGY, 1997, 157 (02): : 638 - 640
  • [38] Can higher doses of oxybutynin improve efficacy in neurogenic bladder?
    Bennett, N
    O'Leary, M
    Patel, AS
    Xavier, M
    Erickson, JR
    Chancellor, MB
    JOURNAL OF UROLOGY, 2004, 171 (02): : 749 - 751
  • [39] Demonstration of bladder selective muscarinic receptor binding by intravesical oxybutynin to treat overactive bladder
    Oki, T
    Kimura, R
    Saito, M
    Miyagawa, I
    Yamada, S
    JOURNAL OF UROLOGY, 2004, 172 (05): : 2059 - 2064
  • [40] Formulation study of intravesical oxybutynin instillation solution with enhanced retention in bladder
    Hanawa, Takehisa
    Tsuchiya, Chikako
    Endo, Naoko
    Hanawa, Kazumi
    Suzuki, Masahiko
    Suzuki, Taeko
    Mohri, Kiminori
    Oguchi, Toshio
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2008, 56 (08) : 1073 - 1076
12345